Brown, Lisle/Cummings, Inc. Merck & Co., Inc. Transaction History
Brown, Lisle/Cummings, Inc.
- $376 Billion
- Q2 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 33,085 shares of MRK stock, worth $2.66 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
33,085
Previous 35,415
6.58%
Holding current value
$2.66 Million
Previous $3.18 Billion
17.61%
% of portfolio
0.7%
Previous 0.92%
Shares
15 transactions
Others Institutions Holding MRK
# of Institutions
3,835Shares Held
1.95BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$20.3 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.52 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.17 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.73 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $203B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...